Price Alert

Forte Biosciences Inc. (FBRX)

NASDAQ: FBRX · Real-Time Price · USD

11.85

1.03 (9.52%)

At close: Aug 15, 2025, 3:59 PM

11.61

-2.03%

After-hours: Aug 15, 2025, 04:53 PM EDT

Forte Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	45.86M	22.24M	16.36M	24.5M	10.63M	11.96M	21.14M	20.44M	35.9M	41.1M	44.05M	38.55M	40.03M	42.04M	45.66M	50.8M	54.76M
Short-Term Investments	n/a	36.12M	n/a	n/a	19.81M	25.16M	25.04M	9.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	176K	138K	192K	271K	409K	544K	679K	407K	437K	486K	534K	874K	893K	786K	834K	936K	1.11M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	449K	336K	274K	313K	233K	165K	94K	129K	109K	70K	119K	94K	89K	89K	119K	139K	144K
Total Current Assets	47.16M	61.35M	17.67M	25.71M	31.5M	38.33M	47.1M	30.75M	36.27M	41.51M	44.59M	38.85M	40.41M	42.52M	46.56M	51.88M	55.87M
Property-Plant & Equipment	125K	77K	86K	96K	106K	109K	98K	30K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	70K	83K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	301K	215K	278K	367K	515K	653K	777K	437K	437K	486K	534K	874K	893K	786K	834K	1.01M	1.2M
Total Assets	47.46M	61.56M	17.95M	26.08M	32.02M	38.98M	47.88M	31.18M	36.71M	42M	45.13M	39.72M	41.3M	43.31M	47.39M	52.89M	57.07M
Account Payables	5.02M	4.88M	5.16M	5.28M	1.69M	1.42M	5.35M	3.01M	1.34M	1.15M	1.19M	698K	576K	946K	2.33M	985K	1.21M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.25M	1.55M	1.22M	1.03M	834K	947K	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	9.03M	9.08M	8.58M	9.12M	3.33M	3.67M	7.47M	6.3M	3.76M	3.18M	2.29M	1.51M	1.26M	1.76M	3.74M	2.98M	2.37M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.34M	1.15M	1.19M	698K	576K	946K	n/a	n/a	n/a
Total Liabilities	9.03M	9.08M	8.58M	9.12M	3.33M	3.67M	7.47M	6.3M	3.76M	3.18M	2.29M	1.51M	1.26M	1.76M	3.74M	2.98M	2.37M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	6K	6K	1K	36K	36K	36K	36K	21K	21K	21K	21K	15K	15K	15K	15K	14K	13K
Retained Earnings	-169.65M	-154M	-146.84M	-138.45M	-125.94M	-118.52M	-112.65M	-102.69M	-93.8M	-87.04M	-82.17M	-78.77M	-75.73M	-73.17M	-69.82M	-62.07M	-56.26M
Comprehensive Income	n/a	11K	1K	-7K	-2K	4K	-5K	1K	n/a	n/a	n/a	n/a	-41.3M	0.00	-47.39M	-52.89M	-57.07M
Shareholders Equity	38.43M	52.48M	9.37M	16.96M	28.68M	35.31M	40.41M	24.88M	32.95M	38.82M	42.84M	38.21M	40.05M	41.55M	43.65M	49.91M	54.7M
Total Investments	n/a	36.12M	n/a	14.92M	19.81M	25.16M	25.04M	9.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a